Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD.

Csoma B, Bikov A, Nagy L, Tóth B, Tábi T, Szűcs G, Komlósi ZI, Müller V, Losonczy G, Lázár Z.

Respir Res. 2019 Jul 16;20(1):156. doi: 10.1186/s12931-019-1133-8.

2.

Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer.

Szentkereszty M, Komlósi ZI, Szűcs G, Barna G, Tamási L, Losonczy G, Gálffy G.

Pathol Oncol Res. 2019 May 14. doi: 10.1007/s12253-019-00661-w. [Epub ahead of print]

PMID:
31090020
3.

Effects of aging on corneal parameters measured with Pentacam in healthy subjects.

Vitályos G, Kolozsvári BL, Németh G, Losonczy G, Hassan Z, Pásztor D, Fodor M.

Sci Rep. 2019 Mar 4;9(1):3419. doi: 10.1038/s41598-019-39234-x.

4.

Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD.

Böcskei RM, Benczúr B, Losonczy G, Illyés M, Cziráki A, Müller V, Bohács A, Bikov A.

Lung. 2019 Apr;197(2):189-197. doi: 10.1007/s00408-019-00211-w. Epub 2019 Feb 28.

5.

Comprehensive coronary plaque assessment in patients with obstructive sleep apnea.

Bikov A, Kolossváry M, Jermendy AL, Drobni ZD, Tarnoki AD, Tarnoki DL, Forgó B, Kovacs DT, Losonczy G, Kunos L, Voros S, Merkely B, Maurovich-Horvat P.

J Sleep Res. 2019 Feb 6:e12828. doi: 10.1111/jsr.12828. [Epub ahead of print]

PMID:
30724416
6.

Association Between Serum Lipid Profile and Obstructive Respiratory Events During REM and Non-REM Sleep.

Bikov A, Lazar Z, Horvath P, Tarnoki DL, Tarnoki AD, Fesus L, Horvath M, Meszaros M, Losonczy G, Kunos L.

Lung. 2019 Feb 2. doi: 10.1007/s00408-019-00195-7. [Epub ahead of print]

PMID:
30712133
7.

The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study.

Tolnay E, Ghimessy ÁK, Juhász E, Sztancsik Z, Losonczy G, Dombi P, Vennes Z, Helf L, Csada E, Sárosi V.

Oncol Lett. 2019 Feb;17(2):1750-1760. doi: 10.3892/ol.2018.9766. Epub 2018 Nov 27.

8.

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.

Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV; IMpower133 Study Group.

N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25.

PMID:
30280641
9.

A suitable protocol for measuring alveolar nitric oxide in asthma with differing severity to assess peripheral airways inflammation.

Lázár Z, Horváth P, Puskás R, Gálffy G, Losonczy G, Horváth I, Bikov A.

J Asthma. 2019 Jun;56(6):584-593. doi: 10.1080/02770903.2018.1477957. Epub 2018 Oct 30.

PMID:
29923757
10.

Central and peripheral airway nitric oxide in patients with stable and exacerbated chronic obstructive pulmonary disease.

Lázár Z, Kelemen Á, Gálffy G, Losonczy G, Horváth I, Bikov A.

J Breath Res. 2018 May 29;12(3):036017. doi: 10.1088/1752-7163/aac10a.

PMID:
29813036
11.

Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer.

Gerber DE, Horn L, Boyer M, Sanborn R, Natale R, Palmero R, Bidoli P, Bondarenko I, Germonpre P, Ghizdavescu D, Kotsakis A, Lena H, Losonczy G, Park K, Su WC, Tang M, Lai J, Kallinteris NL, Shan JS, Reck M, Spigel DR.

Ann Oncol. 2018 Jul 1;29(7):1548-1553. doi: 10.1093/annonc/mdy177.

PMID:
29767677
12.

Complement system activation in obstructive sleep apnea.

Horvath P, Tarnoki DL, Tarnoki AD, Karlinger K, Lazar Z, Losonczy G, Kunos L, Bikov A.

J Sleep Res. 2018 Dec;27(6):e12674. doi: 10.1111/jsr.12674. Epub 2018 Mar 1.

PMID:
29493039
13.

Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung Cancer.

von Pawel J, Spigel DR, Ervin T, Losonczy G, Barlesi F, Juhász E, Anderson M, McCall B, Wakshull E, Hegde P, Ye W, Chen D, Chang I, Rhee I, Reck M.

Oncologist. 2018 Jun;23(6):654-e58. doi: 10.1634/theoncologist.2017-0690. Epub 2018 Feb 7.

14.

Relative anterior microphthalmos in oculodentodigital dysplasia.

Orosz O, Fodor M, Balogh I, Losonczy G.

Indian J Ophthalmol. 2018 Feb;66(2):334-336. doi: 10.4103/ijo.IJO_756_17.

15.

Circulating Clusterin and Osteopontin Levels in Asthma and Asthmatic Pregnancy.

Dombai B, Ivancsó I, Bikov A, Oroszi D, Bohács A, Müller V, Rigó J Jr, Vásárhelyi B, Losonczy G, Tamási L.

Can Respir J. 2017;2017:1602039. doi: 10.1155/2017/1602039. Epub 2017 Oct 23.

16.

Role of lung volume and airway inflammation in obstructive sleep apnea.

Bikov A, Losonczy G, Kunos L.

Respir Investig. 2017 Nov;55(6):326-333. doi: 10.1016/j.resinv.2017.08.009. Epub 2017 Sep 22. Review.

PMID:
29153412
17.

Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells.

Komlósi ZI, Kovács N, van de Veen W, Kirsch AI, Fahrner HB, Wawrzyniak M, Rebane A, Stanic B, Palomares O, Rückert B, Menz G, Akdis M, Losonczy G, Akdis CA.

J Allergy Clin Immunol. 2018 Jul;142(1):178-194.e11. doi: 10.1016/j.jaci.2017.07.046. Epub 2017 Sep 20.

18.

Myopia and Late-Onset Progressive Cone Dystrophy Associate to LVAVA/MVAVA Exon 3 Interchange Haplotypes of Opsin Genes on Chromosome X.

Orosz O, Rajta I, Vajas A, Takács L, Csutak A, Fodor M, Kolozsvári B, Resch M, Sényi K, Lesch B, Szabó V, Berta A, Balogh I, Losonczy G.

Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1834-1842. doi: 10.1167/iovs.16-21405.

PMID:
28358949
19.

Cultivation of Human Oral Mucosal Explants on Contact Lenses.

Zsebik B, Ujlaky-Nagy L, Losonczy G, Vereb G, Takács L.

Curr Eye Res. 2017 Aug;42(8):1094-1099. doi: 10.1080/02713683.2017.1279635. Epub 2017 Mar 24.

PMID:
28339301
20.

Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure.

Lorx A, Czövek D, Gingl Z, Makan G, Radics B, Bartusek D, Szigeti S, Gál J, Losonczy G, Sly PD, Hantos Z.

Eur Respir J. 2017 Feb 15;49(2). pii: 1601270. doi: 10.1183/13993003.01270-2016. Print 2017 Feb.

21.

Seasonal changes of lower respiratory tract infections in lung transplant recipients during the first post-transplant year: The Hungarian experience.

Kovats Z, Bohacs A, Sutto Z, Vincze K, Lukacsovits J, Losonczy G, Müller V.

Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12671. Epub 2017 Mar 11.

PMID:
28164439
22.

Diurnal variation of circulating microvesicles is associated with the severity of obstructive sleep apnoea.

Bikov A, Kunos L, Pállinger É, Lázár Z, Kis A, Horváth G, Losonczy G, Komlósi ZI.

Sleep Breath. 2017 Sep;21(3):595-600. doi: 10.1007/s11325-017-1464-y. Epub 2017 Jan 27.

PMID:
28130736
23.

Correction of irregular and induced regular corneal astigmatism with toric IOL after posterior segment surgery: a case series.

Kolozsvári BL, Losonczy G, Pásztor D, Fodor M.

BMC Ophthalmol. 2017 Jan 13;17(1):3. doi: 10.1186/s12886-016-0397-8.

24.

Overnight Changes in Lung Function of Obese Patients with Obstructive Sleep Apnoea.

Kunos L, Lazar Z, Martinovszky F, Tarnoki AD, Tarnoki DL, Kovacs D, Forgo B, Horvath P, Losonczy G, Bikov A.

Lung. 2017 Feb;195(1):127-133. doi: 10.1007/s00408-016-9957-1. Epub 2016 Oct 21.

PMID:
27770204
25.

Ceritinib in second and further lines of therapy in advanced ALK mutant adenocarcinoma.

Losonczy G.

J Thorac Dis. 2016 Jul;8(7):E584-5. doi: 10.21037/jtd.2016.05.53. No abstract available.

26.

Circulating periostin level in asthmatic pregnancy.

Ivancsó I, Bohács A, Szalay B, Toldi G, Szilasi ME, Müller V, Losonczy G, Rigó J Jr, Vásárhelyi B, Tamási L.

J Asthma. 2016 Nov;53(9):900-6. doi: 10.3109/02770903.2016.1165697. Epub 2016 Jun 24.

PMID:
27340880
27.

Femtosecond laser-assisted keratoplasty combined with cataract extraction in a patient with keratoconus and oculocutaneous albinism.

Pásztor D, Kolozsvári BL, Losonczy G, Fodor M.

Indian J Ophthalmol. 2016 Mar;64(3):246-8. doi: 10.4103/0301-4738.181743.

28.

The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial.

Reck M, Socinski MA, Luft A, Szczęsna A, Dediu M, Ramlau R, Losonczy G, Molinier O, Schumann C, Gralla RJ, Bonomi P, Brown J, Soldatenkova V, Chouaki N, Obasaju C, Peterson P, Thatcher N.

J Thorac Oncol. 2016 Jun;11(6):808-18. doi: 10.1016/j.jtho.2016.03.002. Epub 2016 Mar 12.

29.

Long time enzyme replacement therapy stabilizes obstructive lung disease and alters peripheral immune cell subsets in Fabry patients.

Odler B, Cseh Á, Constantin T, Fekete G, Losonczy G, Tamási L, Benke K, Szilveszter B, Müller V.

Clin Respir J. 2017 Nov;11(6):942-950. doi: 10.1111/crj.12446. Epub 2016 Feb 18.

PMID:
26763180
30.

Relationship of Circulating C5a and Complement Factor H Levels With Disease Control in Pregnant Women With Asthma.

Bohács A, Bikov A, Ivancsó I, Czaller I, Böcskei R, Müller V, Rigó J Jr, Losonczy G, Tamási L.

Respir Care. 2016 Apr;61(4):502-9. doi: 10.4187/respcare.04339. Epub 2016 Jan 12.

31.

TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial.

Quoix E, Lena H, Losonczy G, Forget F, Chouaid C, Papai Z, Gervais R, Ottensmeier C, Szczesna A, Kazarnowicz A, Beck JT, Westeel V, Felip E, Debieuvre D, Madroszyk A, Adam J, Lacoste G, Tavernaro A, Bastien B, Halluard C, Palanché T, Limacher JM.

Lancet Oncol. 2016 Feb;17(2):212-223. doi: 10.1016/S1470-2045(15)00483-0. Epub 2015 Dec 23.

PMID:
26727163
32.

Exhaled breath condensate pH decreases following oral glucose tolerance test.

Bikov A, Pako J, Montvai D, Kovacs D, Koller Z, Losonczy G, Horvath I.

J Breath Res. 2015 Dec 15;9(4):047112. doi: 10.1088/1752-7155/9/4/047112.

PMID:
26669903
33.

Presence of Fleischer ring and prominent corneal nerves in keratoconus relatives and normal controls.

Kriszt Á, Losonczy G, Berta A, Takács L.

Int J Ophthalmol. 2015 Oct 18;8(5):922-7. doi: 10.3980/j.issn.2222-3959.2015.05.12. eCollection 2015.

34.

Exhaled Breath Condensate pH in Lung Cancer, the Impact of Clinical Factors.

Bikov A, Lazar Z, Gyulai N, Szentkereszty M, Losonczy G, Horvath I, Galffy G.

Lung. 2015 Dec;193(6):957-63. doi: 10.1007/s00408-015-9778-7. Epub 2015 Aug 11.

PMID:
26260979
35.

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.

Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy G, Kazarnowicz A, Park K, Schumann C, Reck M, Depenbrock H, Nanda S, Kruljac-Letunic A, Kurek R, Paz-Ares L, Socinski MA; SQUIRE Investigators.

Lancet Oncol. 2015 Jul;16(7):763-74. doi: 10.1016/S1470-2045(15)00021-2. Epub 2015 Jun 1.

36.

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.

Paz-Ares L, Mezger J, Ciuleanu TE, Fischer JR, von Pawel J, Provencio M, Kazarnowicz A, Losonczy G, de Castro G Jr, Szczesna A, Crino L, Reck M, Ramlau R, Ulsperger E, Schumann C, Miziara JE, Lessa ÁE, Dediu M, Bálint B, Depenbrock H, Soldatenkova V, Kurek R, Hirsch FR, Thatcher N, Socinski MA; INSPIRE investigators.

Lancet Oncol. 2015 Mar;16(3):328-37. doi: 10.1016/S1470-2045(15)70046-X. Epub 2015 Feb 18.

37.

Ophthalmological phenotype associated with homozygous null mutation in the NEUROD1 gene.

Orosz O, Czeglédi M, Kántor I, Balogh I, Vajas A, Takács L, Berta A, Losonczy G.

Mol Vis. 2015 Feb 5;21:124-30. eCollection 2015.

38.

Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.

Bikov A, Hernadi M, Korosi BZ, Kunos L, Zsamboki G, Sutto Z, Tarnoki AD, Tarnoki DL, Losonczy G, Horvath I.

BMC Pulm Med. 2014 Dec 16;14:202. doi: 10.1186/1471-2466-14-202.

39.

Plasma VEGF levels and their relation to right ventricular function in pulmonary hypertension.

Pako J, Bikov A, Karlocai K, Csosza G, Kunos L, Losonczy G, Horvath I.

Clin Exp Hypertens. 2015;37(4):340-4. doi: 10.3109/10641963.2014.972561. Epub 2014 Oct 27.

PMID:
25347703
40.

Circulating survivin levels in healthy and asthmatic pregnancy.

Bikov A, Bocskei R, Eszes N, Bohacs A, Losonczy G, Rigo J, Horvath I, Tamasi L.

Reprod Biol Endocrinol. 2014 Sep 23;12:93. doi: 10.1186/1477-7827-12-93.

41.

Exhaled breath temperature in patients with stable and exacerbated COPD.

Lázár Z, Bikov A, Martinovszky F, Gálffy G, Losonczy G, Horváth I.

J Breath Res. 2014 Sep 18;8(4):046002. doi: 10.1088/1752-7155/8/4/046002.

PMID:
25234010
42.

Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer.

Podmaniczky E, Fábián K, Pápay J, Puskás R, Gyulai M, Furák J, Tiszlavicz L, Losonczy G, Tímár J, Moldvay J.

Pathol Oncol Res. 2015 Apr;21(2):423-31. doi: 10.1007/s12253-014-9839-x. Epub 2014 Sep 7.

PMID:
25194563
43.

Effectiveness of erlotinib treatment in advanced KRAS mutation-negative lung adenocarcinoma patients: Results of a multicenter observational cohort study (MOTIVATE).

Sarosi V, Losonczy G, Francovszky E, Tolnay E, Torok S, Galffy G, Hegedus B, Dome B, Ostoros G.

Lung Cancer. 2014 Oct;86(1):54-8. doi: 10.1016/j.lungcan.2014.07.011. Epub 2014 Jul 27.

PMID:
25129367
44.

[Gefitinib treatment in lung cancer -- rebiopsy, retreatment, remission].

Moldvay J, Pápay J, Kovalszky I, Balázs G, Puskás R, Losonczy G.

Magy Onkol. 2014 Jun;58(2):133-7. Epub 2014 Mar 5. Hungarian.

45.

Caloric restriction confers persistent anti-oxidative, pro-angiogenic, and anti-inflammatory effects and promotes anti-aging miRNA expression profile in cerebromicrovascular endothelial cells of aged rats.

Csiszar A, Gautam T, Sosnowska D, Tarantini S, Banki E, Tucsek Z, Toth P, Losonczy G, Koller A, Reglodi D, Giles CB, Wren JD, Sonntag WE, Ungvari Z.

Am J Physiol Heart Circ Physiol. 2014 Aug 1;307(3):H292-306. doi: 10.1152/ajpheart.00307.2014. Epub 2014 Jun 6.

46.

Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose.

Kunos L, Bikov A, Lazar Z, Korosi BZ, Benedek P, Losonczy G, Horvath I.

Sleep Breath. 2015 Mar;19(1):247-53. doi: 10.1007/s11325-014-1003-z. Epub 2014 May 20.

PMID:
24840212
47.

Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy.

Eszes N, Toldi G, Bohács A, Ivancsó I, Müller V, Rigó J Jr, Losonczy G, Vásárhelyi B, Tamási L.

PLoS One. 2014 Apr 15;9(4):e94678. doi: 10.1371/journal.pone.0094678. eCollection 2014.

48.

Unicentric mixed variant Castleman disease associated with intrabronchial plasmacytoma.

Eszes N, Tamási L, Csekeő A, Csomor J, Szepesi A, Varga G, Balázs G, Losonczy G, Müller V.

Diagn Pathol. 2014 Mar 20;9:64. doi: 10.1186/1746-1596-9-64.

49.

Segregation analysis suggests that keratoconus is a complex non-mendelian disease.

Kriszt A, Losonczy G, Berta A, Vereb G, Takács L.

Acta Ophthalmol. 2014 Nov;92(7):e562-8. doi: 10.1111/aos.12389. Epub 2014 Mar 16.

50.

Peripheral CD4+ cell prevalence and pleuropulmonary manifestations in systemic lupus erythematosus patients.

Vincze K, Kovats Z, Cseh A, Pasti K, Kiss E, Polgar A, Vasarhelyi B, Szabo AJ, Bohacs A, Tamasi L, Losonczy G, Müller V.

Respir Med. 2014 May;108(5):766-74. doi: 10.1016/j.rmed.2014.02.006. Epub 2014 Feb 18.

Supplemental Content

Loading ...
Support Center